Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Desglucosylempagliflozin 4,4’-DImer is an impurity of Empagliflozin (E521510), a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats.